MedPath

Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM)

Not Applicable
Recruiting
Conditions
Very Low Birth Weight Infant
Registration Number
NCT05308134
Lead Sponsor
The Hospital for Sick Children
Brief Summary

Very low birth weight infants have increased nutritional needs. Extra nutrients are added to their human milk feeds to help improve their nutritional status, growth and neurodevelopment. Standard fortification of human milk is routine in most neonatal units in North America, but despite the added nutrients, infants are often discharged from hospitals with poor growth, and their neurodevelopment remains suboptimal. Two individualized fortification methods, target and BUN adjustable, have been proposed to improve the nutrient supply to infants. However, there is currently insufficient evidence to support the implementation of individualized fortification or one method over the other. Therefore, this study will randomly assign very low birth weight infants to receive feeds fortified according to standard, target or BUN adjustable fortification methods until the end of the feeding intervention. Feedings will be prepared in milk preparation rooms to ensure caregivers and outcomes assessor remain blinded to feeding allocation. Growth, morbidities, and nutrient intakes will be determined throughout hospitalization and skinfolds assessed at 36 weeks. At 4 months CA, growth and body composition will be determined by air displacement plethysmography on a subset of infants. Neurodevelopment will be assessed using the Bayley Scales of Infant and Toddler Development, at 18-24 months CA.

Detailed Description

The end of the feeding intervention is defined as: the infant is 36+0 weeks CA, is discharged home, or receives two oral feeds daily for three consecutive days without top-up. The exception to the 36+0 weeks intervention end-date is in the situation where an infant remains hospitalized but has not completed at least four weeks of the feeding intervention (i.e. 4 weeks following Study Day 1).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
615
Inclusion Criteria
  • ≤1250 g birth weight or Gestational Age <30+0 weeks and <1500 g birth weight.
  • Parental/guardian consent to participate.
  • Consent for the use of pasteurized donor milk if mother's milk is not available.
Exclusion Criteria
  • Infant received fortifier or formula before Study Day 1.
  • Study Day 1 to occur after postnatal day 21.
  • Infants with congenital or chromosomal anomalies or brain injury that may affect growth or neurodevelopment.
  • Enrollment in any other clinical study affecting nutritional management during the feeding intervention.
  • Reasonable potential that the infant will be transferred to a NICU where the study protocol will not be continued before they have completed at least 4 weeks of the feeding intervention.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Cognitive Composite Score18-24 months corrected age

Bayley Scales of Infant and Toddler Development

Secondary Outcome Measures
NameTimeMethod
Language Composite Score18-24 months CA

Bayley Scales of Infant and Toddler Development

Motor Composite Score18-24 months CA

Bayley Scales of Infant and Toddler Development

Weight Gain during the interventionStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first

Change in z-score

Length gain during the interventionStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first

Change in z-score

Head circumference gain during the interventionStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first

Change in z-score

Body composition at the end of the intervention36 weeks corrected age

Skinfolds

Serious MorbidityStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first

Composite of death, NEC, late onset sepsis, chronic lung disease or severe retinopathy of prematurity (ROP)

Health EconomicsStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs first

Total cost incurred for in-hospital care

Weight at follow-up4 months corrected age

z score

Length at follow-up4 months corrected age

z score

Head Circumference at follow-up4 months corrected age

z score

Body composition at follow-up (approximated)4 months corrected age

Skinfolds

Body composition at follow-up (direct measurement)4 months corrected age

Air displacement plethysmography

Trial Locations

Locations (20)

University of Alberta

🇨🇦

Edmonton, Alberta, Canada

William Osler Health System-Brampton Civic Hospital

🇨🇦

Brampton, Ontario, Canada

William Osler Health System-Etobicoke General Hospital

🇨🇦

Etobicoke, Ontario, Canada

Markham Stouffville Hospital

🇨🇦

Markham, Ontario, Canada

Trillium Health Partners-Missisauga Hospital

🇨🇦

Mississauga, Ontario, Canada

Trillium Health Partners-Credit Valley Hospital

🇨🇦

Mississauga, Ontario, Canada

Southlake Regional Health Centre

🇨🇦

Newmarket, Ontario, Canada

North York General Hospital

🇨🇦

North York, Ontario, Canada

Humber River Hospital

🇨🇦

North York, Ontario, Canada

Lakeridge Health

🇨🇦

Oshawa, Ontario, Canada

Scroll for more (10 remaining)
University of Alberta
🇨🇦Edmonton, Alberta, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.